Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to B-cell Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL
- Status
- RECRUITING
- Phase
- PHASE2
CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction
- Status
- RECRUITING
- Phase
- NA
Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients
- Status
- RECRUITING
- Phase
- NA
Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical Trial
- Status
- RECRUITING
- Phase
- PHASE1
Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
CD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL
- Status
- RECRUITING
- Phase
- PHASE1
QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Study of HY004 Treatment in Adult Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r B-ALL)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinical Research
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Co-administration of CART22-65s and huCART19 for B-ALL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALL
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
- Status
- RECRUITING
- Phase
- PHASE2
Novel Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2